title: Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation.
abstract: Systemic autoimmune disease (AID) can be controlled with conventional therapies in most patients. However, relapses are common, leading to progressive disability and premature death. Nonmyeloablative conditioning and allogeneic bone marrow transplantation (BMT) could be an effective treatment for severe AID, because of mild toxicity of the conditioning and the potential benefits of donor chimerism. We examined the effects of this treatment in experimental autoimmune arthritis. Our results demonstrate the induction of complete donor chimerism and significant suppression of disease activity. No clinical graft-versus-host disease (GVHD) was observed. The beneficial effects were most likely caused by the elimination of plasma cells producing pathogenic autoantibodies, because these antibodies disappeared rapidly after BMT. Although this type of treatment was effective in organ-specific T-cell-mediated AID, the present study provides convincing evidence that nonmyeloablative conditioning and allogeneic BMT can effectively treat severe B-cell-mediated AID with a systemic inflammatory component.
authors.affiliation: Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, C4-R, 2300 RC, Leiden, The Netherlands. r.flierman@lumc.nl
authors.forename: Roelof
authors.initials: R
authors.lastname: Flierman
authors.forename: Hendrik J
authors.initials: HJ
authors.lastname: Witteveen
authors.forename: Ellen I H
authors.initials: EI
authors.lastname: van der Voort
authors.forename: Tom W J
authors.initials: TW
authors.lastname: Huizinga
authors.forename: René R P
authors.initials: RR
authors.lastname: de Vries
authors.forename: Willem E
authors.initials: WE
authors.lastname: Fibbe
authors.forename: René E M
authors.initials: RE
authors.lastname: Toes
authors.forename: Jacob M
authors.initials: JM
authors.lastname: van Laar
mesh_terms: D000818:Animals; D001323:Autoantibodies / Q000097:blood; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D001402:B-Lymphocytes / Q000276:immunology*; D016026:Bone Marrow Transplantation / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology; D006650:Histocompatibility Testing; D008285:Major Histocompatibility Complex / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D010950:Plasma Cells / Q000276:immunology; D019172:Transplantation Conditioning
chemical_list: D001323:Autoantibodies